
Pancreatobiliary cancer is currently difficult to treat as it continues to increase compared to the tumors in other areas. KUMC Pancreatobiliary Center is established in order to provide world-class medical services for the life extension and improvement of the quality of life of the patients based on the latest treatment techniques and active research.
Pancreatic/biliary tract cancer ranked 10th to 12th in the frequency of cancer incidence rate, and 8th to 10th in males for the overall cancer incidence rate per organ in Korea.
In addition, the occurrence of pancreatic/biliary tract cancer is expected to increase further due to the growth in the elderly population, high smoking rate, and Westernization of diet. Clinical symptoms are nonspecific; however, abdominal pain, jaundice, and weight loss may occur. Pancreatic/biliary tract cancer should be suspected in patients with these symptoms, and diagnostic tests must be performed early.
Diagnostic tests include blood tests, ultrasonography, CT or MRI, endoscopic retrograde cholangiopancreatography, and percutaneous transhepatic cholangiography. PET may be helpful in distinguishing from pancreatitis. The specialized staff at KUMC Pancreatobiliary Center uses state-of-the-art equipment.